Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001246276 | SCV001419619 | likely benign | Ullrich congenital muscular dystrophy 2; Bethlem myopathy 2 | 2023-11-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001760284 | SCV002008781 | uncertain significance | not provided | 2022-12-19 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Revvity Omics, |
RCV001760284 | SCV003833391 | uncertain significance | not provided | 2019-10-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004034859 | SCV004928483 | uncertain significance | Inborn genetic diseases | 2023-12-23 | criteria provided, single submitter | clinical testing | The c.3767A>G (p.H1256R) alteration is located in exon 19 (coding exon 18) of the COL12A1 gene. This alteration results from a A to G substitution at nucleotide position 3767, causing the histidine (H) at amino acid position 1256 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |